Abiomed Submits 510(k) For Impella Ventricular Assist Device
Abiomed hopes to gain FDA market clearance of its Impella 2.5 minimally invasive ventricular assist device later this year following the firm's recent 510(k) submission, announced Feb. 5
Abiomed hopes to gain FDA market clearance of its Impella 2.5 minimally invasive ventricular assist device later this year following the firm's recent 510(k) submission, announced Feb. 5